International Stem Cell (ISCO) EBIAT (2016 - 2025)
Historic EBIAT for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $57000.0.
- International Stem Cell's EBIAT rose 14560.0% to $57000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$59000.0, marking a year-over-year increase of 9129.79%. This contributed to the annual value of -$209000.0 for FY2024, which is 5954.2% down from last year.
- As of Q3 2025, International Stem Cell's EBIAT stood at $57000.0, which was up 14560.0% from $129000.0 recorded in Q2 2025.
- In the past 5 years, International Stem Cell's EBIAT registered a high of $492000.0 during Q2 2023, and its lowest value of -$599000.0 during Q1 2021.
- In the last 5 years, International Stem Cell's EBIAT had a median value of -$34000.0 in 2023 and averaged -$86315.8.
- Examining YoY changes over the last 5 years, International Stem Cell's EBIAT showed a top increase of 2470000.0% in 2023 and a maximum decrease of 209130.43% in 2023.
- International Stem Cell's EBIAT (Quarter) stood at -$351000.0 in 2021, then soared by 106.55% to $23000.0 in 2022, then plummeted by 2091.3% to -$458000.0 in 2023, then surged by 102.4% to $11000.0 in 2024, then surged by 418.18% to $57000.0 in 2025.
- Its EBIAT was $57000.0 in Q3 2025, compared to $129000.0 in Q2 2025 and -$256000.0 in Q1 2025.